Cyrus Harmon

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Shane Kovacs, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cyrus Harmon:

Company Role Class Num Shares Value Price $ Report Date Ownership
Olema Pharmaceuticals, Inc. Director Common Stock 741,259 $21,148,119 $28.53 22 Dec 2025 Direct
Olema Pharmaceuticals, Inc. Director Common Stock 117,028 $3,290,827 $28.12 22 Dec 2025 Indirect
Olema Pharmaceuticals, Inc. Director Stock Option (right to buy) 24,150 11 Jun 2025 Direct

Insider Reports Filed by Cyrus Harmon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OLMA Olema Pharmaceuticals, Inc. 22 Dec 2025 1 -$82,195 4 Director 29 Dec 2025, 21:55
OLMA Olema Pharmaceuticals, Inc. 16 Sep 2025 4 -$204,841 4 Director 18 Sep 2025, 21:30
OLMA Olema Pharmaceuticals, Inc. 11 Jun 2025 1 $0 4 Director 13 Jun 2025, 17:00
OLMA Olema Pharmaceuticals, Inc. 09 Dec 2024 4 -$147,956 4 Director 11 Dec 2024, 19:56
OLMA Olema Pharmaceuticals, Inc. 29 Jul 2024 2 -$77,872 4 Director 31 Jul 2024, 17:15
OLMA Olema Pharmaceuticals, Inc. 11 Jul 2024 1 -$61,300 4 Director 12 Jul 2024, 17:15
OLMA Olema Pharmaceuticals, Inc. 28 Jun 2024 1 -$215,400 4 Director 02 Jul 2024, 17:30
OLMA Olema Pharmaceuticals, Inc. 14 Jun 2024 1 $0 4 Director 18 Jun 2024, 17:00
OLMA Olema Pharmaceuticals, Inc. 31 May 2024 3 -$257,450 4 Director 04 Jun 2024, 21:00
OLMA Olema Pharmaceuticals, Inc. 06 May 2024 1 -$54,600 4 Director 07 May 2024, 17:00
OLMA Olema Pharmaceuticals, Inc. 30 Apr 2024 1 -$142,650 4 Director 02 May 2024, 17:09
OLMA Olema Pharmaceuticals, Inc. 28 Mar 2024 1 -$219,400 4 Director 29 Mar 2024, 17:00
OLMA Olema Pharmaceuticals, Inc. 29 Feb 2024 2 -$310,309 4 Director 04 Mar 2024, 17:30
OLMA Olema Pharmaceuticals, Inc. 31 Jan 2024 2 -$383,550 4 Director 02 Feb 2024, 17:00
OLMA Olema Pharmaceuticals, Inc. 29 Dec 2023 2 -$334,500 4 Director 02 Jan 2024, 17:30
OLMA Olema Pharmaceuticals, Inc. 30 Nov 2023 1 -$314,250 4 Director 01 Dec 2023, 17:15
OLMA Olema Pharmaceuticals, Inc. 20 Nov 2023 3 -$117,740 4 Director 22 Nov 2023, 19:00
OLMA Olema Pharmaceuticals, Inc. 31 Oct 2023 2 -$379,450 4 Director 02 Nov 2023, 20:50
OLMA Olema Pharmaceuticals, Inc. 29 Sep 2023 1 -$310,250 4 Director 03 Oct 2023, 17:00
OLMA Olema Pharmaceuticals, Inc. 31 Aug 2023 2 -$256,600 4 Director 05 Sep 2023, 21:08
OLMA Olema Pharmaceuticals, Inc. 16 Aug 2023 1 -$152,100 4/A Director 05 Sep 2023, 16:05
OLMA Olema Pharmaceuticals, Inc. 08 Jun 2023 1 -$63,000 4 Director 09 Jun 2023, 17:30
OLMA Olema Pharmaceuticals, Inc. 05 Jun 2023 2 -$61,700 4 Director 07 Jun 2023, 21:30
OLMA Olema Pharmaceuticals, Inc. 01 Feb 2023 1 $0 4 Chief Research Officer, Director 02 Feb 2023, 16:23
OLMA Olema Pharmaceuticals, Inc. 01 Feb 2022 1 $0 4 CHIEF TECHNOLOGY OFFICER, Director 03 Feb 2022, 18:10
OLMA Olema Pharmaceuticals, Inc. 29 Nov 2021 1 -$9,904 4 CHIEF TECHNOLOGY OFFICER, Director 01 Dec 2021, 16:34
OLMA Olema Pharmaceuticals, Inc. 19 Oct 2021 2 -$335,794 4 CHIEF TECHNOLOGY OFFICER, Director 21 Oct 2021, 16:33
OLMA Olema Pharmaceuticals, Inc. 20 Sep 2021 1 -$315,600 4 CHIEF TECHNOLOGY OFFICER, Director 21 Sep 2021, 18:19
OLMA Olema Pharmaceuticals, Inc. 19 Aug 2021 1 -$299,640 4 CHIEF TECHNOLOGY OFFICER, Director 20 Aug 2021, 21:14
OLMA Olema Pharmaceuticals, Inc. 20 Jul 2021 2 -$301,258 4 CHIEF TECHNOLOGY OFFICER, Director 21 Jul 2021, 17:29
OLMA Olema Pharmaceuticals, Inc. 18 Jun 2021 3 -$297,626 4 CHIEF TECHNOLOGY OFFICER, Director 21 Jun 2021, 19:05